The pharmaceutical industry is experiencing rapid advances in biologics, with biopharmaceuticals delivering novel, targeted treatments that are transforming patient care. Across the Asia-Pacific region, leading organisations such as CSL, Pfizer, Biocon, Samsung Biologics, ThermoFisher, and WuXi, along with numerous small to medium-sized enterprises, are investing heavily to expand their capabilities and scale operations from research and development through to manufacturing.
The BioProcessing Network (BPN), established in Australia, plays a vital role in advancing knowledge and understanding of the technical aspects of the biopharmaceutical sector. As part of its mission, BPN hosts an annual conference that explores critical topics such as:
SeerPharma has a long history of supporting organisations in navigating the complexities of GMP compliance — from Investigational Medicinal Products (Phase II and beyond) through to full commercialisation. With the growing number of research-driven and early-stage companies entering the biologics space, we are increasingly engaged in helping lay the foundations of GMP for Experimental Medicinal Products (Phases 0 and I). These early activities are critical to ensuring the safety, quality, and eventual success of new therapies.
As part of our efforts in industry, SeerPharma has been invited to present at the 2025 BPN Conference, taking place in Melbourne from 15–17 September 2025.
The presentation will be delivered by SeerPharma GxP Compliance Manager – Michelle Peake, who will cover the core GMP requirements for Experimental Medicinal Product manufacturing and remind participants that GMP isn’t just bureaucracy designed to slow organisations down, but in fact the difference between a novel discovery and a safe, effective medicine that patients can receive.
For further details on the conference, please visit: https://www.bioprocessingnetwork.org.au/Conference-2025-Preconference/
To learn more about how we support our clients, do visit:
Supporting leading events, in sharing our knowledge, is just another way we further our mission to “Advance Quality and GMP Best-Practices in the APAC Region”.